Objective To observe the sensitivity of stroke volume variation(SVV) for assessing volume change during induction period of general anesthesia. Methods Patients who underwent orthopaedic surgery under general anesthes...Objective To observe the sensitivity of stroke volume variation(SVV) for assessing volume change during induction period of general anesthesia. Methods Patients who underwent orthopaedic surgery under general anesthesia and mechanical ventilation were divided into two groups randomly. Patients in the group Ⅰwere subjected to progressive central hypovolemia and correction of hypovolemia sequentially; patients in the Group Ⅱ were exposed to hypervolemia alone. Each step was implemented after 5 minutes when the hemodynamics was stable. SVV and cardiac index(CI) were recorded, and Pearson's product-moment correlation was used to analyze correlation between SVV and CI. Results Forty patients were included in this study, 20 cases in each group. For group Ⅰ patients, SVV was increased significantly along with blood volume reduction, and changes in CI were negatively correlated with changes in SVV(r=-0.605, P<0.01); SVV decreased significantly along with correction of blood volume; changes in CI were negatively correlated with changes in SVV(r=-0.651, P<0.01). For group Ⅱ patients, along with blood volume increase, SVV did not change significantly; changes in CI revealed no significant correlation with changes in SVV(r=0.067, P>0.05). Conclusion SVV is a useful indicator for hypovolemia, but not for hypervolemia.展开更多
Purpose: Central venous pressure (CVP) is considered to be unsuitable as preload parameter. Stroke volume variation (SVV) has recently been reported to be effective as a preload and fluid responsiveness parameter, and...Purpose: Central venous pressure (CVP) is considered to be unsuitable as preload parameter. Stroke volume variation (SVV) has recently been reported to be effective as a preload and fluid responsiveness parameter, and its usefulness for fluid management during living-donor liver transplantation (LDLT). However, use of SVV has not been reported in children. Our aim is to evaluate the use of SVV as a target parameter of circulating blood volume during pediatric LDLT. Methods: This retrospective study was conducted in 40 consecutive patients aged between 5 and 109 months who underwent elective LDLT. Twenty patients underwent LDLT without FloTrac? (C group) and the rest patients underwent LDLT with the FloTrac? monitoring (F group). As a fluid management target, CVP was maintained at 10 mmHg in the C group and SVV at 10% in the F group. We compared MAP and CVP at the times of the greatest decrease within 5 minutes after reperfusion. Results: MAP after reperfusion was significantly decreased in both groups (P < 0.01), with the magnitude of decrease significantly greater in the C group compared with the F group (P = 0.02). MAP before and after reperfusion did not significantly differ between the groups. After reperfusion, CVP was nearly the same in both groups, with that in the C group slightly decreased and nearly no change in the F group. SVV after reperfusion was significantly increased (P < 0.001). Conclusion: When used as a target parameter for fluid management during pediatric LDLT, hemodynamic changes was less when SVV was used as the parameter of circulating blood volume.展开更多
Objective: SVV is derived from the cardiopulmonary interaction, which is used to predict the responsiveness of cardiac preload guiding fluid therapy in patients under general anesthesia in non-opened chest surgery. Fr...Objective: SVV is derived from the cardiopulmonary interaction, which is used to predict the responsiveness of cardiac preload guiding fluid therapy in patients under general anesthesia in non-opened chest surgery. From a clinical point of view, it is important to know how well SVV reflects preload and fluid responsiveness during cardiac surgery. This study was undertaken to assess the accuracy and reliability of SVV derived from the FloTrac/Vigileo system in monitoring changes in blood volume in patients undergoing off-pump coronary artery bypass grafting (OPCABG) under general anesthesia. Methods: After approval from the ethics committee and obtaining the permission of the patients, twenty-nine patients, ASA II-III and NYHA II-III, aged 44-7 yr, undergoing elective off-pump coronary artery bypass grafting, were randomly divided into 2 groups: the control group (group C, n = 8) and volume expansion group (group V, n = 21). After patients entered the operating room, veins were put in line, ECG, HR, SpO2, and PETCO2 were continuously monitored. Left radial arterial and right internal jugular vein catheters were inserted under local anesthesia. The FloTracTM/VigileoTM system was connected and MAP, CO, CI, SVV, SV, SVI, SVR, SVRI, CVP were continuously monitored. BIS values were kept at 45%-55.6% hydroxyethyl starch 130/0.4 sodium chloride solution 7 ml/kg was intravenously infused after completion of sternotomy and pericardiotomy at a rate of 0.25 ml/kg–1/min–1 in group V. MAP, HR, CVP, systemic vascular resistance (SVR), SVV, and stroke volume index (SVI) were determined 10 min before (T1) and after the infusion of finished (T2), and the change rate (ΔHR, ΔMAP, ΔCVP, ΔSVR, ΔSVV, ΔSVI) was calculated. Sodium chloride injection 3 ml/kg was infused in group C. Results: CVP, SVI, CO and CI were increased after volume expansion, SVRI and SVV significantly decreased in group V(P < 0.01), while MAP and HR were not changed. Changes in HR(r = –0.737, P and SVR(r = –0.480, P were significantly correlated to changes in SVI, but there was no correlation between ΔCVP, ΔMAP, ΔSVV and ΔSVI.展开更多
目的心肺交互作用指标SVV、PPV能较好地预测机械通气患者液体反应,但其预测效能可能受潮气量和PEEP水平的影响,本研究旨在评价SVV、PPV预测ARDS(实施小潮气量+PEEP的保护性通气策略)患者液体反应的价值。方法将2009年7月～2011年1月期...目的心肺交互作用指标SVV、PPV能较好地预测机械通气患者液体反应,但其预测效能可能受潮气量和PEEP水平的影响,本研究旨在评价SVV、PPV预测ARDS(实施小潮气量+PEEP的保护性通气策略)患者液体反应的价值。方法将2009年7月～2011年1月期间入住笔者所在科室的11例ARDS患者纳入研究,PiCCO进行动态血流动力学监测,记录基础SVV、PPV、心排出量指数(CI)、血管外肺水指数(ELWI)、氧输送指数(DO2I)等数据后进行容量负荷试验:6%羟乙基淀粉250ml在30min内匀速静脉输注后,若心排出量增加(△CI)<15%(无反应),则结束试验;若△CI≥15%(有反应),则再进行一次容量负荷试验后结束试验(作为两人次试验),每次容量负荷试验后均收集上述数据。按△CI将患者分为有反应组和无反应组,再根据PEEP水平将患者分为PEEP<10cmH2O和PEEP>10cmH2O两个亚组,分析各变量的变化。结果有反应组和无反应组补液前基础SVV、PPV无显著差异(11.4±5.1 vs 14.2±5.9,P>0.05)、(11.0±5.0 vs 9.4±4.6,P>0.05);低PEEP组有反应患者和无反应患者补液前基础SVV、PPV无显著差异(9.8±3.8 vs 16.5±6.4,P>0.05)、(9.9±2.7 vs 12.1±3.8,P>0.05);高PEEP组有反应患者和无反应患者补液前基础SVV、PPV也无显著差异(14.0±6.8 vs 11.4±4.1,P>0.05)、(13.0±8.0 vs 6.2±3.6,P>0.05)。补液后,有反应组CI显著增加(5.3±0.2 vs 4.5±0.3,P<0.05),无反应组CI显著减少(4.3±0.4 vs 4.6±0.4,P<0.05)、DO2I显著减少(416±35 vs 463±31,P<0.05),补液前后两组ELWI、PaO2/FiO2均无明显变化。结论 SVV、PPV不能预测实施肺保护性通气的ARDS的液体反应。展开更多
文摘Objective To observe the sensitivity of stroke volume variation(SVV) for assessing volume change during induction period of general anesthesia. Methods Patients who underwent orthopaedic surgery under general anesthesia and mechanical ventilation were divided into two groups randomly. Patients in the group Ⅰwere subjected to progressive central hypovolemia and correction of hypovolemia sequentially; patients in the Group Ⅱ were exposed to hypervolemia alone. Each step was implemented after 5 minutes when the hemodynamics was stable. SVV and cardiac index(CI) were recorded, and Pearson's product-moment correlation was used to analyze correlation between SVV and CI. Results Forty patients were included in this study, 20 cases in each group. For group Ⅰ patients, SVV was increased significantly along with blood volume reduction, and changes in CI were negatively correlated with changes in SVV(r=-0.605, P<0.01); SVV decreased significantly along with correction of blood volume; changes in CI were negatively correlated with changes in SVV(r=-0.651, P<0.01). For group Ⅱ patients, along with blood volume increase, SVV did not change significantly; changes in CI revealed no significant correlation with changes in SVV(r=0.067, P>0.05). Conclusion SVV is a useful indicator for hypovolemia, but not for hypervolemia.
文摘Purpose: Central venous pressure (CVP) is considered to be unsuitable as preload parameter. Stroke volume variation (SVV) has recently been reported to be effective as a preload and fluid responsiveness parameter, and its usefulness for fluid management during living-donor liver transplantation (LDLT). However, use of SVV has not been reported in children. Our aim is to evaluate the use of SVV as a target parameter of circulating blood volume during pediatric LDLT. Methods: This retrospective study was conducted in 40 consecutive patients aged between 5 and 109 months who underwent elective LDLT. Twenty patients underwent LDLT without FloTrac? (C group) and the rest patients underwent LDLT with the FloTrac? monitoring (F group). As a fluid management target, CVP was maintained at 10 mmHg in the C group and SVV at 10% in the F group. We compared MAP and CVP at the times of the greatest decrease within 5 minutes after reperfusion. Results: MAP after reperfusion was significantly decreased in both groups (P < 0.01), with the magnitude of decrease significantly greater in the C group compared with the F group (P = 0.02). MAP before and after reperfusion did not significantly differ between the groups. After reperfusion, CVP was nearly the same in both groups, with that in the C group slightly decreased and nearly no change in the F group. SVV after reperfusion was significantly increased (P < 0.001). Conclusion: When used as a target parameter for fluid management during pediatric LDLT, hemodynamic changes was less when SVV was used as the parameter of circulating blood volume.
文摘Objective: SVV is derived from the cardiopulmonary interaction, which is used to predict the responsiveness of cardiac preload guiding fluid therapy in patients under general anesthesia in non-opened chest surgery. From a clinical point of view, it is important to know how well SVV reflects preload and fluid responsiveness during cardiac surgery. This study was undertaken to assess the accuracy and reliability of SVV derived from the FloTrac/Vigileo system in monitoring changes in blood volume in patients undergoing off-pump coronary artery bypass grafting (OPCABG) under general anesthesia. Methods: After approval from the ethics committee and obtaining the permission of the patients, twenty-nine patients, ASA II-III and NYHA II-III, aged 44-7 yr, undergoing elective off-pump coronary artery bypass grafting, were randomly divided into 2 groups: the control group (group C, n = 8) and volume expansion group (group V, n = 21). After patients entered the operating room, veins were put in line, ECG, HR, SpO2, and PETCO2 were continuously monitored. Left radial arterial and right internal jugular vein catheters were inserted under local anesthesia. The FloTracTM/VigileoTM system was connected and MAP, CO, CI, SVV, SV, SVI, SVR, SVRI, CVP were continuously monitored. BIS values were kept at 45%-55.6% hydroxyethyl starch 130/0.4 sodium chloride solution 7 ml/kg was intravenously infused after completion of sternotomy and pericardiotomy at a rate of 0.25 ml/kg–1/min–1 in group V. MAP, HR, CVP, systemic vascular resistance (SVR), SVV, and stroke volume index (SVI) were determined 10 min before (T1) and after the infusion of finished (T2), and the change rate (ΔHR, ΔMAP, ΔCVP, ΔSVR, ΔSVV, ΔSVI) was calculated. Sodium chloride injection 3 ml/kg was infused in group C. Results: CVP, SVI, CO and CI were increased after volume expansion, SVRI and SVV significantly decreased in group V(P < 0.01), while MAP and HR were not changed. Changes in HR(r = –0.737, P and SVR(r = –0.480, P were significantly correlated to changes in SVI, but there was no correlation between ΔCVP, ΔMAP, ΔSVV and ΔSVI.
文摘目的心肺交互作用指标SVV、PPV能较好地预测机械通气患者液体反应,但其预测效能可能受潮气量和PEEP水平的影响,本研究旨在评价SVV、PPV预测ARDS(实施小潮气量+PEEP的保护性通气策略)患者液体反应的价值。方法将2009年7月～2011年1月期间入住笔者所在科室的11例ARDS患者纳入研究,PiCCO进行动态血流动力学监测,记录基础SVV、PPV、心排出量指数(CI)、血管外肺水指数(ELWI)、氧输送指数(DO2I)等数据后进行容量负荷试验:6%羟乙基淀粉250ml在30min内匀速静脉输注后,若心排出量增加(△CI)<15%(无反应),则结束试验;若△CI≥15%(有反应),则再进行一次容量负荷试验后结束试验(作为两人次试验),每次容量负荷试验后均收集上述数据。按△CI将患者分为有反应组和无反应组,再根据PEEP水平将患者分为PEEP<10cmH2O和PEEP>10cmH2O两个亚组,分析各变量的变化。结果有反应组和无反应组补液前基础SVV、PPV无显著差异(11.4±5.1 vs 14.2±5.9,P>0.05)、(11.0±5.0 vs 9.4±4.6,P>0.05);低PEEP组有反应患者和无反应患者补液前基础SVV、PPV无显著差异(9.8±3.8 vs 16.5±6.4,P>0.05)、(9.9±2.7 vs 12.1±3.8,P>0.05);高PEEP组有反应患者和无反应患者补液前基础SVV、PPV也无显著差异(14.0±6.8 vs 11.4±4.1,P>0.05)、(13.0±8.0 vs 6.2±3.6,P>0.05)。补液后,有反应组CI显著增加(5.3±0.2 vs 4.5±0.3,P<0.05),无反应组CI显著减少(4.3±0.4 vs 4.6±0.4,P<0.05)、DO2I显著减少(416±35 vs 463±31,P<0.05),补液前后两组ELWI、PaO2/FiO2均无明显变化。结论 SVV、PPV不能预测实施肺保护性通气的ARDS的液体反应。
